| Literature DB >> 18250464 |
Khaled Ali1, Montserrat Camps, Wayne P Pearce, Hong Ji, Thomas Rückle, Nicolas Kuehn, Christian Pasquali, Christian Chabert, Christian Rommel, Bart Vanhaesebroeck.
Abstract
The leukocyte-enriched p110gamma and p110delta isoforms of PI3K have been shown to control in vitro degranulation of mast cells induced by cross-linking of the high affinity receptor of IgE (FcepsilonRI). However, the relative contribution of these PI3K isoforms in IgE-dependent allergic responses in vivo is controversial. A side-by-side comparative analysis of the role of p110gamma and p110delta in mast cell function, using genetic approaches and newly developed isoform-selective pharmacologic inhibitors, confirms that both PI3K isoforms play an important role in FcepsilonRI-activated mast cell degranulation in vitro. In vivo, however, only p110delta was found to be required for optimal IgE/Ag-dependent hypersensitivity responses in mice. These observations identify p110delta as a key therapeutic target among PI3K isoforms for allergy- and mast cell-related diseases.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18250464 PMCID: PMC2643005 DOI: 10.4049/jimmunol.180.4.2538
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422